Acta Medica (Hradec Kralove Czech Republic) · 2000 · 18 citations · 37 references
Life SciencesCell BiologyPharmacologyApoptosisCell SignalingNeurodegenerationApoptosis In CancerApoptosis PharmacologyApoptosis RegulationApoptotic SignalingBcl-2 Family ProteinsCell DeathApoptosis In Chronic InflammationApoptosis Signaling PathwaysIntrinsic Apoptosis PathwayLysosomal-mediated Cell DeathMitochondrial Cell Death PathwaysMitochondrial Pathway Of ApoptosisProgrammed Cell Death PathwaysProgrammed Cell Death Regulation
Rapidly growing body of evidence on cell death mechanisms and its disorders during last five years has replaced old paradigms and opened new horizons in medicine. Identification of different morphological and signaling aspects, as well as variances in requirement for energy enabled us to construct a theory of three main types of cell death: necrosis, apoptosis, and lysosomal cell death. Mitochondria, certain oncoproteins such as Bcl-2 family, and special catabolic enzymes participating in cellular demise might serve as targets for pharmacological manipulation. Upregulation or downregulation of programmed cell death has been implicated in ischemic, neurodegenerative, and autoimmune disorders, as well as in oncology and chronic inflammation. This minireview brings a short overview of genesis and development of theories on programmed cell death and apoptosis, summarizes basic relevant facts on apoptotic mechanisms and draws a new hypothesis on possible implication in medicine and surgery.
37
Molecular characterization of mitochondrial apoptosis-inducing factor
Santos A. Susín, Hans Kristian Lorenzo, Naoufal Zamzami et al. · Nature · 1999 · 4K citations
A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD
Masato Enari, Hideki Sakahira, Hideki Yokoyama et al. · Nature · 1998 · 3.2K citations
Thymocyte apoptosis induced by p53-dependent and independent pathways
Alan R. Clarke, Colin A. Purdie, David J. Harrison et al. · Nature · 1993 · 2.3K citations